Navigation Links
Plavix, Heartburn Drug Safe to Take Together: Study
Date:9/21/2010

By Steven Reinberg
HealthDay Reporter

TUESDAY, Sept. 21 (HealthDay News) -- A new study finds it's safe to take the blood thinner Plavix with proton-pump inhibitors like Nexium, contrary to recent research that said the combination compromised Plavix's effectiveness.

"We looked into this highly debated area of clopidogrel [Plavix] and proton-pump inhibitors," said lead researcher Dr. Mette Charlot from the department of cardiology at Copenhagen University Hospital Gentofte in Hellerup, Denmark. "We did not find any evidence of drug interaction."

Proton-pump inhibitors are heartburn drugs. Doctors often prescribe the two drugs in combination to prevent clotting and reduce the risk of stomach bleeding, which can be a serious complication for patients taking Plavix, the researchers said.

This study is larger than studies that found an interaction between the drugs, and this data included patients who were taking PPIs but not Plavix, Charlot noted.

"What we actually found was an increased risk related to the use of proton-pump inhibitors, but we found the risk was the same in patients treated with clopidogrel and patients not treated with clopidogrel," Charlot said.

For the study, published in the Sept. 21 issue of the Annals of Internal Medicine and funded by the Danish Medical Research Council and the Danish Heart Foundation, Charlot's team collected outcome data on 56,406 patients across Denmark who had a first heart attack between 2000 and 2006. Follow-up was one year.

Sixteen percent were rehospitalized for a heart attack or stroke, or died. Of the 44 percent of patients who took Plavix, 27 percent also took a PPI, the researchers say.

Patients taking both medications had a 29 percent increased risk of rehospitalization for a heart attack or stroke, or death. However, among patients taking only a PPI, the risk of these adverse events was also 29 percent, the researchers found.

The researchers concluded that the increased risk of a heart attack, stroke or death is associated with PPIs, and not the combination of Plavix and a PPI.

"We are confident that the feared interaction between the two drugs does not happen," Charlot said. "We believe that patients who have an indication for PPI treatment should definitely be treated with PPIs to avoid the risk of gastrointestinal bleeding," she added.

Dr. James Brophy, a professor of medicine and epidemiology at the Royal Victoria Hospital in Montreal, Canada, said this new research carries more weight than the earlier studies.

This study "appears to be of superior quality to several previous reports," said Brophy, author of an accompanying journal editorial. "There is not high quality evidence supporting a meaningful drug interaction between clopidogrel and PPIs," he said.

"While unnecessary drug prescribing is always to be avoided, the current evidence suggests that patients taking clopidogrel can take a PPI," Brophy said.

Additional studies would be helpful, Brophy added, "but in the interim, the dangers of bleeding from avoiding PPIs may well be greater than any cardiac risks from inhibiting clopidogrel."

More information

For more information on the Plavix-PPI combo, visit the U.S. Food and Drug Administration.

SOURCES: Mette Charlot, M.D., department of cardiology, Copenhagen University Hospital Gentofte, Hellerup, Denmark; James Brophy, M.D., Ph.D., professor, medicine and epidemiology, Royal Victoria Hospital, Montreal; Sept. 21, 2010, Annals of Internal Medicine


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. FDA Warns of Fracture Risk With Popular Heartburn Drugs
2. Coming Soon: A Low-Heartburn Coffee?
3. A century-old puzzle comes together: Scientists ID potential protein trigger in lung disease sarcoidosis
4. Study Claims Flu Shots Associated With Lower Risk of Heart Attack
5. Investigational eye treatment: Corneal collagen crosslinking research study
6. For Common Warts, Freezing Therapy Works Best: Study
7. Study: How Palestinian and Israeli children are psychologically scarred by exposure to war
8. Study: Mental illness stigma entrenched in American culture; new strategies needed
9. Successful periodontal therapy may reduce the risk of preterm birth, according to Penn dental study
10. New study finds positive return on investment for states that invest in quit smoking treatments
11. In Vitro Fertilization Success Rate Higher in Spring, Study Suggests
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Plavix, Heartburn Drug Safe to Take Together: Study
(Date:12/8/2016)... MA (PRWEB) , ... December 08, 2016 , ... ... Workers Compensation Research Institute (WCRI) officially opened registration today for its 33rd ... Hotel in Boston, MA . , The theme of the conference is “Persistent ...
(Date:12/8/2016)... ... 08, 2016 , ... CURE Media Group, the nation’s leading digital and print ... Upstage Lung Cancer in efforts to combat lung cancer, announced CURE Media Group President ... “CURE Media Group is honored to team up with Upstage Lung Cancer in order ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... development continuity to its innovative Unified Instance Manager architecture, meeting the needs ... this new version optimizes the unattended auto-dialing system without agents, Presence Robodialer, ...
(Date:12/8/2016)... City, Ga (PRWEB) , ... December 08, 2016 ... ... moving as soon after surgery as possible. With this in mind, SIGVARIS has ... thrombosis (DVT or blood clot) during bed rest and provide the benefits of ...
(Date:12/8/2016)... , ... December 08, 2016 , ... ... planning services from offices headquartered in Jefferson County, is announcing the launch of ... in Birmingham. , The number of homeless women and children in Birmingham has ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... Pharmacy, Inc. (NYSE: DPLO) has been recognized by the Detroit ... Standard. To learn more about Diplomat,s career opportunities, visit ... ... ... LLC, a research firm specializing in organizational health and workplace improvement. ...
(Date:12/8/2016)... 8, 2016  Eli Lilly and Company (NYSE: ... phase 3 EXPEDITION3 trial at the 9 th ... disclosed, solanezumab did not meet the primary endpoint in ... in people with mild dementia due to Alzheimer,s disease ... solanezumab for the treatment of mild dementia due to ...
(Date:12/8/2016)... Dec 8, 2016 Research and Markets has ... and Trends - Adhesion Type, Application, Usability - Forecast to 2025" ... , ... Electrodes Market is poised to grow at a CAGR of around ... the market is witnessing include advancements in extracellular microelectrode arrays and ...
Breaking Medicine Technology: